Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIMEGEPANT vs RISPERDAL CONSTA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIMEGEPANT vs RISPERDAL CONSTA: Safety Overview

Metric RIMEGEPANT RISPERDAL CONSTA
Total FAERS Reports 9,175 140
Deaths Reported 77 29
Death Rate 0.8% 20.7%
Hospitalizations 217 56
Average Patient Age 50.7 yrs 45.0 yrs
% Female Patients 85.5% N/A
FDA Approval Date Feb 27, 2020 N/A
Manufacturer Sportpharm, Inc. dba Sportpharm N/A
Route ORAL N/A
Marketing Status Prescription N/A